Welcome to Shanghai Probechem Biochemicals Co Ltd !Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : LY2109761
CAS No.: 700874-71-1
Catalog No.: PC-42887Not For Human Use, Lab Use Only.
LY2109761 is a potent, selective and orally active TGF-β RI/II dual inhibitor with Ki of 38/300 nM, respectively.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 10 mg | $88 | In stock | |
| 25 mg | $148 | In stock | |
| 50 mg | $238 | In stock | |
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
LY2109761 is a potent, selective and orally active TGF-β RI/II dual inhibitor with Ki of 38/300 nM, respectively.
LY2109761 completely inhibits TGF-β-induced Sma2 phosphorylation on tumor cells or the liver microenviroment, inhibits the L3.6pl/GLT soft agar growth。
LY2109761 suppresses both basal and TGF-β1-induced cell migration and invasion, and stimulates anoikis in vitro。
LY2109761 significantly reduces the tumor burden as well as spontaneous abdominal metastases, and prolongs survival combined with gemicitabine in vivo model of pancreatic cancer.
| M.Wt | 441.5249 | |
| Formula | C26H27N5O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
Quinoline, 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]- |
|
1. Mazzocca A, et al. Hepatology. 2009 Oct;50(4):1140-51.
2. Zhang M, et al. Cancer Res, 2011, 71(23), 7155-7167.
3. Melisi D, et al. Mol Cancer Ther, 2008, 7(4), 829-840.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
